吸烟、更年期早期和多发性硬化症病程。

IF 2.9 4区 医学 Q1 OBSTETRICS & GYNECOLOGY Climacteric Pub Date : 2023-12-01 Epub Date: 2023-06-30 DOI:10.1080/13697137.2023.2221381
Nur Neyal, Elizabeth J Atkinson, Carin Y Smith, Delana M Weis, Liliana Gazzuola Rocca, Walter A Rocca, Kejal Kantarci, Orhun H Kantarci, Burcu Zeydan
{"title":"吸烟、更年期早期和多发性硬化症病程。","authors":"Nur Neyal, Elizabeth J Atkinson, Carin Y Smith, Delana M Weis, Liliana Gazzuola Rocca, Walter A Rocca, Kejal Kantarci, Orhun H Kantarci, Burcu Zeydan","doi":"10.1080/13697137.2023.2221381","DOIUrl":null,"url":null,"abstract":"<p><p>Smoking is associated with an increased risk of multiple sclerosis (MS), and smoking and early menopause are related to poor outcomes in MS. Smoking is also associated with early menopause. To explore this intricate relationship between smoking status, age at menopause and disease course in MS, 137 women with MS and 396 age-matched controls were included in this case-control study. Age at menopause (median 49.0 vs. 50.0 years; <i>p</i> = 0.79) and smoking status (40.3% vs. 47.6%; <i>p</i> = 0.15) were similar among MS and control women. Relapsing MS onset was earlier in ever-smoker women with early menopause compared to the rest of the women (median 30.4 vs. 37.0 years; <i>p</i> = 0.02) and also compared to ever-smoker women with normal age at menopause (median 30.4 vs. 41.0 years; <i>p</i> = 0.008) and never-smoker women with early menopause (median 30.4 vs. 41.5 years; <i>p</i> = 0.004). Progressive MS onset was also earlier in ever-smoker women with early menopause compared to ever-smoker women with normal age at menopause (median 41.1 vs. 49.4 years; <i>p</i> = 0.05) and never-smoker women with early menopause (median 41.1 vs. 50.1 years; <i>p</i> = 0.12). Our results suggest that smoking and menopause associate with MS disease course, including the onset of relapsing and progressive MS in women.</p>","PeriodicalId":10213,"journal":{"name":"Climacteric","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756919/pdf/","citationCount":"0","resultStr":"{\"title\":\"Smoking, early menopause and multiple sclerosis disease course.\",\"authors\":\"Nur Neyal, Elizabeth J Atkinson, Carin Y Smith, Delana M Weis, Liliana Gazzuola Rocca, Walter A Rocca, Kejal Kantarci, Orhun H Kantarci, Burcu Zeydan\",\"doi\":\"10.1080/13697137.2023.2221381\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Smoking is associated with an increased risk of multiple sclerosis (MS), and smoking and early menopause are related to poor outcomes in MS. Smoking is also associated with early menopause. To explore this intricate relationship between smoking status, age at menopause and disease course in MS, 137 women with MS and 396 age-matched controls were included in this case-control study. Age at menopause (median 49.0 vs. 50.0 years; <i>p</i> = 0.79) and smoking status (40.3% vs. 47.6%; <i>p</i> = 0.15) were similar among MS and control women. Relapsing MS onset was earlier in ever-smoker women with early menopause compared to the rest of the women (median 30.4 vs. 37.0 years; <i>p</i> = 0.02) and also compared to ever-smoker women with normal age at menopause (median 30.4 vs. 41.0 years; <i>p</i> = 0.008) and never-smoker women with early menopause (median 30.4 vs. 41.5 years; <i>p</i> = 0.004). Progressive MS onset was also earlier in ever-smoker women with early menopause compared to ever-smoker women with normal age at menopause (median 41.1 vs. 49.4 years; <i>p</i> = 0.05) and never-smoker women with early menopause (median 41.1 vs. 50.1 years; <i>p</i> = 0.12). Our results suggest that smoking and menopause associate with MS disease course, including the onset of relapsing and progressive MS in women.</p>\",\"PeriodicalId\":10213,\"journal\":{\"name\":\"Climacteric\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756919/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Climacteric\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13697137.2023.2221381\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/6/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Climacteric","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13697137.2023.2221381","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

吸烟与多发性硬化症(MS)的风险增加有关,吸烟和更年期提前与MS的不良预后有关。吸烟也与更年期提前有关。为了探讨吸烟状况、更年期年龄和多发性硬化症病程之间的复杂关系,本病例对照研究纳入了137名多发性痴呆症女性和396名年龄匹配的对照组。更年期年龄(中位数49.0 vs.50.0岁;p = 0.79)和吸烟状况(40.3%对47.6%;p = 0.15)在MS和对照组妇女中相似。与其他女性相比,绝经早期吸烟女性的复发性多发性硬化症发作更早(中位数30.4对37.0 年;p = 0.02),并且与更年期正常年龄的吸烟女性相比(中位数30.4对41.0 年;p = 0.008)和从不吸烟的更年期早期女性(中位数30.4对41.5 年;p = 0.004)。与绝经年龄正常的吸烟女性相比,绝经早期的吸烟女性进展性多发性硬化症的发病时间也更早(中位数41.1对49.4 年;p = 0.05)和从不吸烟的绝经早期女性(中位数41.1对50.1 年;p = 0.12)。我们的研究结果表明,吸烟和更年期与多发性硬化症的病程有关,包括女性复发和进行性多发性痴呆症的发作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Smoking, early menopause and multiple sclerosis disease course.

Smoking is associated with an increased risk of multiple sclerosis (MS), and smoking and early menopause are related to poor outcomes in MS. Smoking is also associated with early menopause. To explore this intricate relationship between smoking status, age at menopause and disease course in MS, 137 women with MS and 396 age-matched controls were included in this case-control study. Age at menopause (median 49.0 vs. 50.0 years; p = 0.79) and smoking status (40.3% vs. 47.6%; p = 0.15) were similar among MS and control women. Relapsing MS onset was earlier in ever-smoker women with early menopause compared to the rest of the women (median 30.4 vs. 37.0 years; p = 0.02) and also compared to ever-smoker women with normal age at menopause (median 30.4 vs. 41.0 years; p = 0.008) and never-smoker women with early menopause (median 30.4 vs. 41.5 years; p = 0.004). Progressive MS onset was also earlier in ever-smoker women with early menopause compared to ever-smoker women with normal age at menopause (median 41.1 vs. 49.4 years; p = 0.05) and never-smoker women with early menopause (median 41.1 vs. 50.1 years; p = 0.12). Our results suggest that smoking and menopause associate with MS disease course, including the onset of relapsing and progressive MS in women.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Climacteric
Climacteric 医学-妇产科学
CiteScore
1.70
自引率
7.10%
发文量
53
审稿时长
1 months
期刊介绍: Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women. Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments. The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.
期刊最新文献
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion. Hyaluronic acid and erbium laser for the treatment of genitourinary syndrome of menopause. Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index. Heartwired for change: advancing women's cardiovascular health. Physician-patient alignment on menopause-associated symptom burden: real-world evidence from the USA and Europe.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1